FDA authorizes drug combination for coronavirus treatment
The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with ...
The FINANCIAL -- The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug baricitinib, in combination with ...
The FINANCIAL -- Gilead Sciences, Inc. (Nasdaq: GILD) announced that the U.S. Food and Drug Administration (FDA) has approved the ...
The FINANCIAL -- The CoVID-19 Plasma Alliance, an unprecedented collaboration of leading plasma companies supported by global organizations outside the ...
The FINANCIAL -- A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus ...
The FINANCIAL -- The European Commission has signed a joint procurement framework contract with the pharmaceutical company Gilead for the supply ...